Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 01-2003 | 01-2002 | 01-2001 | |
| Sales | 2,837 | 3,240 | 4,079 | 8,210 | 5,532 |
| Cost of Goods | 3,053 | 2,838 | 3,205 | 5,106 | 2,504 |
| Gross Profit | -216 | 402 | 874 | 3,104 | 3,028 |
| Operating Expenses | 3,204 | 4,406 | 4,320 | 3,494 | 4,477 |
| Operating Income | -3,367 | -3,166 | -3,240 | -284 | -945 |
| Interest Expense | 370 | 214 | 47 | 13 | 6 |
| Other Income | 0 | 110 | 24 | 22 | -273 |
| Pre-tax Income | -3,737 | -3,270 | -3,264 | -275 | -1,224 |
| Income Tax | N/A | 13 | -261 | -17 | 277 |
| Net Income Continuous | -3,659 | -3,200 | -2,925 | -257 | -1,469 |
| Net Income | $-3,659 | $-3,200 | $-2,925 | $-257 | $-1,469 |
| EPS Basic Total Ops | -0.75 | -0.68 | -0.64 | -0.06 | -0.32 |
| EPS Basic Continuous Ops | -0.75 | -0.68 | -0.64 | -0.06 | -0.32 |
| EPS Diluted Total Ops | -0.75 | -0.68 | -0.64 | -0.06 | -0.32 |
| EPS Diluted Continuous Ops | -0.75 | -0.68 | -0.64 | -0.06 | -0.32 |
| EBITDA(a) | $-2,583 | $-2,397 | $-2,604 | $154 | $-794 |